Table 3.
Evolution of the treatment response expressed by different standardised measures
| F/U (months) | ACRpedi70 (%) | ACRpedi90 (%) | JADAS inactive (%) | JADAS low activity (%) | CID (%) |
|---|---|---|---|---|---|
| 3 | 28.6 | 12.7 | 5.5 | 21.8 | 9.1 |
| 6 | 50.9 | 42.9 | 32.7 | 47.2 | 30.9 |
| 9 | 56.4 | 50.9 | 43.6 | 54.5 | 47.2 |
| 12 | 70.9 | 63.6 | 56.4 | 61.8 | 56.4 |
F/U, Follow-up visit; CID, Clinically Inactive Disease [40]
Results for 55 patients are shown. Patients who received biologics and/or who withdrew MTX were considered non-responders from the time point of starting the biologic or stopping MTX